A common mutation causing thalassemia in Mediterranean populations is an amber (UAG) nonsense mutation at the 39th codon of the human /3-globin gene, the 18-39 mutation. Studies of mRNA metabolism in erythroblasts from patients with 13-39 thalassemia and studies using heterologous transfection systems have suggested the possibility that this mutation not only affects protein synthesis but also alters mRNA metabolism. The effects of this mutation on several steps in the metabolism of mRNA have been investigated by transfection of the gene into permanent cell lines bearing a temperature-sensitive RNA polymerase II. Several RNA expression studies were performed, including analysis of transcription, mRNA stability, mRNA splicing accuracy, and mRNA polyadenylylation. The results suggest that the defect in expression of the 18-39 mRNA occurs at a step prior to the accumulation of mRNA in the cytoplasm.
evidence for increased turnover of the untranslated /3-globin mRNAs in the cytoplasm. However, these studies have been performed with post-mature erythroblasts and short-term transient expression systems in which the viability ofthe cells ex vivo is far shorter than the reported half-life of the globin mRNA. Therefore, we have studied a well-characterized translation termination codon in permanent cell lines transfected with the defective gene.
We have chosen to study a well-characterized amber mutation that causes /-thalassemia, the /-39 mutation (CAG to UAG at codon 39 of the /3-globin gene). Studies of erythroid cells from affected patients show a dramatic reduction in accumulation of their mRNA (2-5% normal; refs. 1, 4, and 5); data from short-term pulse-chase incubations suggest that the defect in the accumulation of the /3-39 mRNA occurs prior to delivery ofthe mRNA to the cytoplasm. Thus, although the nonsense mutation at codon 39 clearly affects translation, studies from our laboratory and others suggest that this mutation has an additional effect on ,/-globin mRNA metabolism (4, 5, 10, 11) . There is reduced accumulation of the /3-39 mRNA when compared with normal /-globin (/3-nl)
mRNA both in patient's erythrocytes and in a heterologous transient transfection system. Cell-free studies from our own laboratory are in agreement with these in vivo observations (12, 13) . Since there is also reduced accumulation of /-39 mRNA in the nucleus, it has been hypothesized that the defect in expression of the /-39 gene is intranuclear.
Several groups have observed reduced accumulation of nontranslatable globin RNAs. However, very few studies have attempted to compare mRNA turnover to normal. declines of P3-thalassemic mRNAs to steady-state levels after brief pulse incubations of late erythroblasts. Turnover in both cases was so rapid as to be equally consistent with either extreme instability or failure of mRNA synthesis.
Moreover, in cases for which some PO-thalassemic mRNA remained detectable after the pulse, this small amount of mRNA remained stable during prolonged chase incubations.
The unusual phenotype of the /-39 mutation suggests that a novel element in the regulation of gene expression may be uncovered by further investigation. Toward this end, we have constructed and analyzed cell lines that bear the f3-39 and /-nl genes integrated into their genome. Potential differences between expression of the /-39 and 83-nl genes have been studied by comparative analysis of (i) steady-state levels of total, nuclear, and cytoplasmic mRNA; (ii) mRNA half-life; (iii) accuracy of mRNA initiation and splicing; (iv) mRNA polyadenylylation; and (v) transcription initiation. To study mRNA half-life, we have devised a biologic assay that utilizes AF8 cells, a BHK derivative that is temperature-sensitive for RNA polymerase II. AF8 cells were transfected with the /-nl and 3-39 genes and their expression was studied at the permissive and nonpermissive temperatures. At the nonpermissive temperature, RNA polymerase II transcription is blocked. These experiments allowed us to examine /3-globin gene expression at several steps in an effort to identify the defect in /3-39 mRNA metabolism.
MATERIALS AND METHODS
Cell Lines. AF8 cells were obtained from Renato Baserga, Temple University. AF8 cells are a temperature-sensitive RNA polymerase II derivative of BHK, a Syrian hamster cell line (14, 15) . They were maintained in Dulbecco's modified Eagle's medium (DMEM) with lofetal bovine serum, 2 mM glutamine, 50 units of penicillin per ml, and 50 Ag of streptomycin sulfate per ml. The cells were grown at the permissive temperature, 34°C. Experiments at the nonpermissive temperature were performed at 40°C.
Plasmids. The 83-39 and /3-nl globin genes used in these experiments were subcloned into a simian virus 40 (SV40)-based expression vector (4). The /3-39 gene was cloned from a patient with W-thalassemia and the 5-kilobase (kb) Bgl II fragment was subcloned into a pTL9 expression vector. This fragment of the 83-globin gene encodes the putative 3' enhancer. The /-39 gene fragment was sequenced in its entirety (4) and the /3-39 BamHI fragment was re-sequenced (data not shown). pTL9 (5) (20, 21) . Five micrograms of 3-nl or j3-39 plasmid DNA was mixed with 0.5 ug of pSV2neo and 12 jug of calf thymus DNA in 0.5 ml of 280 mM NaCl/50 mM Hepes/1.5 mM sodium phosphate, pH 7.05. An equal volume of 0.25 M CaCl2 was added, and the solution was vortexed and incubated at room temperature for 20-30 min. The precipitate was added to subconfluent AF8 cells in 100-mm plates for 6-12 hr. After dimethyl sulfoxide (20%) shock, the cells were washed with phosphate-buffered saline and incubated overnight at 37°C. The next day the cells were subcultured, and portions (1, 0.8, 0.4, and 0.2 ml) of a 4-ml cell suspension were plated. On the following day the medium was changed and G418 (1 mg/ml) was added for 7 days. On the eighth day, G418 concentration was reduced to 0.5 mg/ml and maintained for 7 more days. At this time, individual colonies of each type were picked with cloning rings and expanded. One plate of 15 colonies of the 3-nl transfection was pooled. All cell lines were maintained in G418 selection (0.5 mg/ml). The cell lines were frozen in dimethyl sulfoxide and stored in liquid nitrogen.
DNA and RNA Isolation. Genomic DNA was isolated from each cell line by the method of Liskay and Evans (22) . All RNA samples were isolated from subconfluent 150-cm2 culture flasks. Total RNA was isolated by the differential precipitation method of Chirgwin et al. (23) . Cytoplasmic and nuclear mRNAs were isolated by Nonidet P-40 lysis using vanadyl ribonucleoside as an RNase inhibitor (24) . Nuclear RNA was isolated from the pellet by the method of Chirgwin et al. (23) .
Southern and Northern Blots. Southern (25) and Northern blot analyses were performed as described (19) . Nicktranslated 32P-labeled probes for Southern and Northern blots were prepared by using the BRL nick-translation kit, according to the manufacturer's directions. All probes were prepared as agarose gel-purified fragments by standard procedures (19) . The probes used were the 1.8-kb BamHI fragment of the human ,B-globin gene and the 0.8-kb Xba I-Pst I fragment of -actin cDNA.
Half-Life Experiments. Two kinds of experiments were performed to determine the relative stability of the 3-39 and ,B-nl mRNAs. One experiment took advantage of the temperature-sensitive RNA polymerase II in AF8 cells. Cells bearing either the (3-nl or the ,3-39 gene were placed at the nonpermissive temperature (40°C) for up to 50 hr. At this temperature, RNA polymerase II activity declines with a half-life of 12 hr. Total RNA was isolated at various times for Northern blot analysis. The relative half-lives of the (3-nl and (8-39 mRNAs were also determined by incubation of the cell lines with actinomycin D (10 Zg/ml) for up to 3 hr. At that time, RNA was isolated for Northern blot analysis. S1 Nuclease Analysis. Total RNA was analyzed by the method of Ley et al. (26) . A uniformly labeled M13 probe was used.
Purification of Poly(A)+ mRNA. Poly(A)+ mRNA was prepared from total or cytoplasmic RNA by passage over oligo(dT)-cellulose (27) . RNA was passed twice over this column.
Nuclear Run-Off Transcription. Nuclear run-off analysis was performed according to Engel et al. (28) . Incorporation of [ac-32P]UTP was standardized to be linear for a reaction length of 10-20 min and 3 x 107 nuclei. Approximately 2 x 106 cpm were hybridized to Southern blots of plasmid DNA. The two plasmids used on the Southern blot contained subclones of the human (3-globin gene and the -actin cDNA.
RESULTS
Transfection of AF8 Cells. Stable transformants of AF8 cells were obtained by cotransfection of the (3-39 or (3-nI gene with pSV2neo. The 83-globin genes were cloned into a pTL9 expression vector. Colonies resistant to G418 (0.5 mg/ml) after 2 weeks of selection were cloned and expanded. Cells from four colonies bearing the (3-nl gene, including one that was a pool of 15 colonies, and cells from four colonies bearing the (3-39 gene were studied in detail.
Southern Blot Analysis. Genomic DNA from these cell lines showed an intact (B-globin gene in all cases (data not shown). In some cell lines a small amount of rearrangement was also seen. In the 83-nl cell lines the copy number varied from 2 to 10 copies per cell, while in the ,(-39 cell lines the copy number was greater than that of the (3- 3) there were also two larger bands that hybridized to the (3-globin probes. By hybridization analysis using probes specific for the non-globin sequences, these were found to be read-through transcripts (data not shown) from the SV40 sequences in the parent plasmid. When the nitrocellulose was stripped and rehybridized to a nick-translated human y-actin probe, it appeared that slightly less RNA was loaded in some of the (3-nl lanes (Fig.  1 Lower) . These experiments indicate that the level of (-39 mRNA is reduced when compared with that of 83-nl mRNA in a stable expression system.
Half-Life Experiments. To elucidate the half-life of the 3-globin mRNAs, we selected AF8, a BHK cell line with a temperature-sensitive RNA polymerase II, as the parent cell line for the transfections. At the nonpermissive temperature, RNA polymerase II activity in these cells decreases with a half-life of 10 hr (29) . At 30 and 50 hr after shift-up to the nonpermissive temperature, RNA polymerase II activity is about 12% and 3%, respectively, of baseline activity and only a small amount of transcription occurs. To analyze the relative half-life of(-nl (wt.1) and (3-39 (39. 2) mRNAs in AF8 cell lines, cells were placed at the nonpermissive temperature (40°C) for 30 and 50 hr. As a control, total RNA was isolated from AF8 cells before shift-up to the nonpermissive temperature. Northern blot data (Fig. 2 Upper) show that both the ,B-nl and the (3-39 lOS mRNAs are stable up to 50 hr after shift-up to the nonpermissive temperature. This number is in good agreement with previous estimates of (-globin mRNA half-life (30) . To check for even loading of mRNA, following hybridization the nitrocellulose was stained with methylene blue, which stains the rRNAs.
To confirm the biological half-life experiments, actinomycin D was added for 3 hr to subconfluent AF8 cells bearing either the P-nl (wt.1) or the (8-39 ( was isolated before addition of the drug and 3 hr after the addition of the drug. The Northern blot (Fig. 2 Lower) indicates that, at least for 3 hr, both the (3-nl and the (3-39 mRNAs are stable in these cell lines.
Hours at 40°C 
DISCUSSION
We have compared the behavior of the human (3-39 mRNA with that of 3-nl mRNA when expressed in mammalian cells and found no evidence for selective instability of the (3-39 mRNA in the cytoplasm. Our studies also argue against a defect in (i) the transcription initiation rate, (ii) the accuracy of transcription initiation and mRNA splicing, or (iii) the polyadenylylation of the (3-39 mRNA and implicate nuclearcytoplasmic transport, nuclear stability, or as yet uncharacterized steps in nuclear mRNA processing. We used two methods to study the stability of the (3-39 mRNA, including one without the use of drugs. Previously, the half-life ofthe c-myc mRNA was determined after shift-up to the nonpermissive temperature in AF8 cells and found to be similar to that determined by other means (31 (33) and actin mRNA in mouse sarcoma ascites cells (34) were stabilized by the addition of actinomycin D. Dreyfuss et al. (35) (36) have described a mutation in a tRNA gene that affects nuclear-cytoplasmic transport of the tRNA. Eisenstein and Rosen (37) have suggested that hormone-stimulated expression of (3-casein mRNA is regulated for the most part by an increase in nuclear stability of the mRNA. More recently, Weil et al. (38) (40) . Data from Pachter et al. (41) are also inconsistent with this argument. Tubulin mRNA pulevl are-affected by the concepntration of free tubuldin subunits; an increase in that concentration decreases the level of tubulin mRNA. The polyribosome profiles presented in ref. 41 indicate that tubulin mRNA is normally associated with polyribosomes in the cell but that tubulin mRNA with a nonsense mutation is not. When the concentration of free tubulin subunits was increased by pharmaceutical means, the level of tubulin mRNA bearing the nonsense mutation was unchanged. The mutant mRNA was actually stabilized. The mutant mRNA was not covered by polyribosomes but was actually less susceptible to degradation than the normal mRNA. "Deprotection" by dissociation from polyribosomes does not necessarily cause an increase in mRNA degradation. In this study we have found that a nonsense mutation that affects the cytoplasmic event of translation also affects intranuclear events. This implies that either there is communication between cytoplasm and nucleus in gene expression or that there is a mechanism that can sense nonsense mutations in the nucleus. The communication could be mediated by an as yet unidentified small cytoplasmic ribonucleoprotein molecule that signals from the cytoplasm to the nucleus when a nonsense mutation is encountered. Or perhaps the communication occurs at the level of the nuclear membrane. Since the nuclear membrane is contiguous with the rough endoplasmic reticulum, it is possible that the mRNA is translated as it is transported across the nuclear membrane. If a nonsense mutation is encountered, the arrest in translation signals an as yet unidentified small nuclear ribonucleoprotein to stop transport ofthat mRNA. Or perhaps the signal is to an endogenous nuclear RNase that selectively digests the mutant ,3 mRNA. It is also possible that the small nuclear ribonucleoprotein binds to the RNA on the nuclear side of the membrane and acts as a marker for the endogenous RNase. It will be possible to study some of these events when an in vitro system for nuclear-cytoplasmic transport has been developed.
